Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

U937 Cells

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on U937 Cells:

Pubmed Logo
Conventional protein kinase C plays a critical role in negative regulation of CD98-induced homotypic aggregation.
CD98, a heterodimeric type II transmembrane protein, is involved in many...
10th November, 2009
1 Department of Immunology and Molecular Pathology, Windeyer Institute of Tissue Antigens. 2009 Nov 6.
DOI Direct Link
Variation in gene expression profiles of human monocytic U937 cells exposed to various fluxes of nitric oxide.
We examined early and late alterations in gene expression patterns and...
7th November, 2009
Centre de Recherche de Gif, Institut de Chimie des Substances Naturelles, Free Radic Biol Med. 2009 Nov 2.
DOI Direct Link
Immunomodulatory properties of Yersinia pestis lipopolysaccharides on human macrophages.
In the current study, we investigated the activity of lipopolysaccharide...
6th November, 2009
Department of Infection and Immunity, School of Medicine, Jichi Medical Clin Vaccine Immunol. 2009 Nov 4.
DOI Direct Link
A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
Bcl-2 protects cancer cells from the apoptotic effects of various...
4th November, 2009
Department of Anatomy and Cell Biology, Dong-A University College of Int J Oncol. 2009 Dec;35(6):1353-60.
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.
BACKGROUND: Gossypol, a naturally occurring polyphenolic compound has been...
27th October, 2009
Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni Radiat Oncol. 2009 Oct 23;4:47.
DOI Direct Link

View more research publications.

Press Releases About U937 Cells:

BioPortfolio Logo
American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 19th November, 2009 American BioSciences
BLAUVELT, N.Y., Nov. 19 /PRNewswire/ -- Dr. Mate Hidvegi, inventor of Avemar fermented wheat germ extract, responds to a press release issued on November 17 by Biropharma Kft, discrediting the
Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Biotechnology Reagents - A Global Market Perspective http://www
Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update 17th November, 2009 Neuralstem, Inc.
ROCKVILLE, Md., Nov. 17 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today provided a financial and business update for the third quarter ended September 30, 2009. (Logo: http://www
Advanced Cell Technology's Chief Scientific Officer, Robert Lanza, Opening Plenary Speaker at the '3rd International Conference on Cell Therapy' 12th November, 2009 Advanced Cell Technology
WORCESTER, Mass., Nov. 12 /PRNewswire-FirstCall/ -- Advanced Cell Technology's (OTCBB: ACTC) Chief Scientific Officer, Robert Lanza, M.D., will be delivering an opening Plenary Lecture at the
Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual Meeting 11th November, 2009 Trubion Pharmaceuticals, Inc.
SEATTLE, Nov. 11 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) announced today the acceptance of two data presentations on its product candidate, TRU-016, at the 2009 American

U937 Cells Clinical Trials:

Clinical Trials Logo
Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"

U937 Cells Patents:

USPTO Logo
US Patent No.Title
7531637 IL-31 monoclonal antibodies
7553641 Tumour necrosis factor binding ligands
7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
7556805 Compositions for treatment of melanoma and method of using same
7560112 Anti-il-6 antibodies, compositions, methods and uses

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for U937 Cells scientists - we have details of around 535 individuals working on U937 Cells .


This page has been viewed 799 times
Recent Search Terms used to find this page: u937 stem cell | U937 cells | U937 patent | u937 cells | working with U937 cells | u937 cells | U937 cells | u937 cells | wikipedia of u937 cell | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for U937 Cells across BioPortfolio, or for U937 Cells Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.